[On iatrogenic damage caused by chemoantibiotic therapy of chronic bronchopneumopathies].
D000799:Angioedema / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002908:Chronic Disease; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D004802:Eosinophilia / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D012769:Shock / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D013449:Sulfonamides
Considerazioni sui danni iatrogenici da chemioantibioticoterapia nelle broncopneumopatie croniche.